Full Press Release Details
Eidos Therapeutics Receives Positive Opinion For Orphan Designation From The European Medicines Agency For AG10, A Potent Oral Stabilizer For The Treatment Of Transthyretin Amyloidosis.
BBIO
Eidos Therapeutics Receives Positive Opinion For Orphan Designation From The European Medicines Agency For AG10, A Potent Oral Stabilizer For The Treatment Of Transthyretin Amyloidosis
Key Takeaway: Eidos Therapeutics Receives Positive Opinion For Orphan Designation From The European Medicines Agency For AG10, A Potent Oral Stabilizer For The Treatment Of Transthyretin Amyloidosis